David Ian Johnson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Ian Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Ian Johnson. David Ian Johnson is a CEO and Chairman in Enveric Biosciences, Inc. ($SPAZ.OB) and a Director in Alliqua BioMedical, Inc. ($ALQA) and a President and CEO in Alliqua BioMedical, Inc. ($ALQA).
Address: C/O ALLIQUA, INC. 850 3RD AVENUE, SUITE 1801 NEW YORK 10022 NY
Companies in which David Ian Johnson is an Insider
Adynxx, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of David Ian Johnson: President and CEO, Director
Holdings: 1,994,535 shares
Current Value: $1,096,994
Latest Transaction: Jun 29 2017
$ALQA Market Capitalization: $17.78M
$ALQA Previous Close: $0.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Enveric Biosciences, Inc.
Industry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of David Ian Johnson: CEO and Chairman
Holdings: 0 shares
Latest Transaction: Feb 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David Ian Johnson
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | SPAZ.OB | Enveric Bioscience ... | Johnson David Ian | CEO and Chairman | Option Exercise | A | 0.00 | 53,192 | 0 | 1,368,999 | |
| Feb 17 2021 | SPAZ.OB | Enveric Bioscience ... | Johnson David Ian | CEO and Chairman | Option Exercise | A | 0.00 | 1,315,807 | 0 | 1,315,807 | |
| Jun 29 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 1,994,535 | 1.7 M to 2 M (+17.70 %) |
| Jun 26 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 500,000 | 0 | 1,694,535 | 1.2 M to 1.7 M (+41.86 %) |
| Apr 04 2017 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Buy | P | 0.40 | 250,000 | 100,000 | 1,194,535 | 944.5 K to 1.2 M (+26.47 %) |
| May 13 2016 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 944,535 | 644.5 K to 944.5 K (+46.55 %) |
| Feb 11 2016 | ALQA | Alliqua BioMedical ... | Johnson David Ian | President and CEO | Grant | A | 0.00 | 59,932 | 0 | 644,535 | 584.6 K to 644.5 K (+10.25 %) |